# PR #88 Merge Authorization Review v0.1

Target PR: #88  
Reviewed exact head: `3731d0bff1def36cc86e3b22de853946fe37feda`  
Reviewed base/main: `765fb9ca1178c47a6ecfc660bd650edb5bffaf8b`

## Result

```text
PR #88 Merge Authorization Review
= REVISE_REQUIRED

BF-PR88-MAR-01
= STALE_PR_SCOPE_AND_MAIN_INTEGRATION_STATE_DESCRIPTION
= OPEN

PR #88
= NOT_ELIGIBLE_FOR_MERGE_AUTHORIZATION_YET

Merge Authorization
= NOT_GRANTED
```

The U03/U04 implementation, clinical-validation, and evidence aggregate itself is not rejected.

Current authoritative status indexes are consistent at the PR #88 / U03 clinical-dependency-completion layer.

Only PR #88 metadata synchronization is required.

Required remediation:

1. Update PR #88 title/body to describe the current complete U03 clinical-dependency + U04 non-production aggregate proposed for main integration.
2. State explicitly that main integration does not authorize production, live routing, release activation, or real-patient traffic.
3. Preserve historical governance records.
4. Do not modify runtime, tests, workflows, U03 clinical truth, U04 RDP semantics, routing, release activation, or production behavior.
5. Perform a targeted PR #88 Merge Authorization Re-Review.

Hard boundaries remain unchanged:

```text
U04 Live Routing Activation = NOT_AUTHORIZED
Clinical Runtime Production = NOT_ENABLED
Production Authorization = BLOCKED
Real-patient traffic = NOT_AUTHORIZED
Main Integration = NOT_COMPLETE
```
